Sanofi (SNY)
Healthcare • Drug Manufacturers - General
StockNasdaqGSFranceUS80105N1054
48.49 USD
+0.05% today Updated 13 Nov 2026 16:06
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Sanofi, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:06. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
28 Jan 2027
in 76 days · 08:00 · estimate 0.87
Last results
1.98 vs 1.51 estimated
30 Oct 2026 · Beat +31.2%
Beat the estimate
9 of 12
3 missed · 0 in line · 5 beats in a row
Average surprise
+5.9%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 28 Jan 2027 08:00 | 0.87 | — | — | Upcoming |
| 30 Oct 2026 02:00 | 1.51 | 1.98 | +31.2% | Beat |
| 30 Jul 2026 01:00 | 1.14 | 1.20 | +5.6% | Beat |
| 23 Apr 2026 01:00 | 1.03 | 1.10 | +7.3% | Beat |
| 29 Jan 2026 01:00 | 0.85 | 0.91 | +7.4% | Beat |
| 24 Oct 2025 10:00 | 1.57 | 1.69 | +8.1% | Beat |
| 30 Jul 2025 20:00 | 1.00 | 0.91 | -9.1% | Miss |
| 24 Apr 2025 01:00 | 0.95 | 1.02 | +7.0% | Beat |
| 30 Jan 2025 01:00 | 0.74 | 0.68 | -7.5% | Miss |
| 25 Oct 2024 04:00 | 1.38 | 1.54 | +11.7% | Beat |
| 25 Jul 2024 01:00 | 0.86 | 0.94 | +9.1% | Beat |
| 25 Apr 2024 01:00 | 0.94 | 0.95 | +1.3% | Beat |
| 01 Feb 2024 01:00 | 0.91 | 0.90 | -1.2% | Miss |
| 27 Oct 2023 12:00 | 1.37 | 1.35 | -1.3% | Miss |
| 28 Jul 2023 15:00 | 0.89 | 0.96 | +8.3% | Beat |
| 27 Apr 2023 01:00 | 1.10 | 1.19 | +8.4% | Beat |
| 03 Feb 2023 11:00 | 0.91 | 0.93 | +2.1% | Beat |
| 28 Oct 2022 01:00 | 1.34 | 1.44 | +7.5% | Beat |
| 28 Jul 2022 02:00 | 0.87 | 0.88 | +0.7% | In line |
| 28 Apr 2022 01:00 | 0.92 | 1.02 | +11.3% | Beat |
| 04 Feb 2022 01:00 | 0.72 | 0.79 | +9.4% | Beat |
| 15 Dec 2021 01:00 | 1.17 | 1.23 | +4.8% | Beat |
| 29 Jul 2021 01:00 | 0.75 | 0.82 | +10.0% | Beat |
| 28 Apr 2021 01:00 | 1.23 | 0.97 | -20.8% | Miss |
| 05 Feb 2021 01:00 | 1.05 | 0.73 | -30.3% | Miss |
| 29 Oct 2020 02:00 | 1.03 | 1.08 | +4.8% | Beat |
| 29 Jul 2020 01:00 | 0.64 | 0.75 | +17.6% | Beat |
| 24 Apr 2020 02:00 | 0.82 | 0.88 | +7.6% | Beat |
| 06 Feb 2020 01:00 | 0.69 | 0.74 | +6.9% | Beat |
| 31 Oct 2019 02:00 | 1.04 | 1.07 | +3.0% | Beat |
| 29 Jul 2019 01:00 | 0.72 | 0.73 | +1.5% | Beat |
| 26 Apr 2019 01:00 | 0.77 | 0.79 | +2.4% | Beat |
| 07 Feb 2019 01:00 | 0.67 | 0.63 | -6.5% | Miss |
| 31 Oct 2018 02:00 | 1.00 | 1.04 | +3.9% | Beat |
| 31 Jul 2018 01:00 | 0.72 | 0.73 | +1.3% | Beat |
| 07 Feb 2018 01:00 | 1.04 | 0.65 | -37.2% | Miss |
| 02 Nov 2017 02:00 | 0.96 | 1.00 | +3.3% | Beat |
| 31 Jul 2017 01:00 | 0.76 | 0.80 | +4.5% | Beat |
| 28 Apr 2017 01:00 | 0.70 | 0.77 | +10.3% | Beat |
| 08 Feb 2017 01:00 | 0.67 | 0.67 | +0.2% | In line |
| 28 Oct 2016 01:00 | 0.80 | 0.98 | +22.0% | Beat |
| 29 Jul 2016 01:00 | 0.72 | 0.73 | +1.8% | Beat |
| 29 Apr 2016 01:00 | 0.77 | 0.77 | -0.8% | In line |
| 09 Feb 2016 01:00 | 0.71 | 0.75 | +4.9% | Beat |
| 29 Oct 2015 02:00 | 0.88 | 0.88 | +0.5% | In line |
| 30 Jul 2015 01:00 | 1.47 | 0.78 | -47.2% | Miss |
| 05 Feb 2015 01:00 | 1.52 | 0.79 | -47.8% | Miss |
| 05 Feb 2014 13:00 | 1.85 | 0.93 | -49.8% | Miss |
| 01 Aug 2013 01:00 | 1.64 | 0.73 | -55.2% | Miss |
| 02 May 2013 01:00 | 1.81 | 0.80 | -56.0% | Miss |
Annual results · EUR
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 46.7B | +5.5% | 7.8B | 16.7% | 3.20 | +39.4% | 7.2B |
| 2024 | 44.3B | +6.4% | 5.6B | 12.6% | 2.30 | +6.5% | 5.9B |
| 2023 | 41.6B | +2.6% | 5.4B | 13.0% | 2.16 | -19.7% | 7.4B |
| 2022 | 40.6B | — | 8.4B | 20.6% | 2.69 | — | 8.4B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | 48.51 | 48.65 | 48.30 | 48.49 | +0.05% | 382,433 | |
| 12 Nov 2026 | 48.89 | 48.96 | 48.40 | 48.46 | +0.06% | 2,364,800 | |
| 11 Nov 2026 | 47.61 | 48.46 | 47.52 | 48.43 | +0.41% | 2,435,100 | |
| 10 Nov 2026 | 48.02 | 48.68 | 47.82 | 48.23 | +0.23% | 4,597,100 | |
| 09 Nov 2026 | 47.99 | 48.46 | 47.53 | 48.12 | +2.30% | 5,771,300 | |
| 06 Nov 2026 | 45.63 | 47.16 | 45.58 | 47.04 | +0.28% | 3,896,200 | |
| 05 Nov 2026 | 47.48 | 47.88 | 46.72 | 46.91 | -1.18% | 7,110,100 | |
| 04 Nov 2026 | 46.85 | 47.49 | 46.46 | 47.47 | +4.72% | 5,483,100 | |
| 03 Nov 2026 | 45.53 | 45.70 | 45.06 | 45.33 | -0.48% | 5,630,500 | |
| 02 Nov 2026 | 44.50 | 45.59 | 44.50 | 45.55 | +2.73% | 7,373,200 | |
| 1,250 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Sanofi (SNY) Is Planning for a Patent Loss, Here’s Where Bulls Still See Opportunity (opens in a new tab) Insider Monkey · 10 Nov 2026 22:22
- NVAX Q3 2026 deep dive: Sanofi milestone and cost controls shape outlook (opens in a new tab) StockStory · 10 Nov 2026 13:01
- Sanofi ADR (NASDAQ:SNY): Dividend Quality Just Clears the Bar (opens in a new tab) ChartMill · 09 Nov 2026 11:41
- Novavax (NVAX) Looks Cheap After Sanofi Milestone And Stronger Q3 Results (opens in a new tab) Simply Wall St. · 07 Nov 2026 16:10
- Is Early B Cell Cancer Data Altering The Investment Case For Nurix Therapeutics (NRIX)? (opens in a new tab) Simply Wall St. · 07 Nov 2026 06:12
- NVAX Stock Falls 8% Despite Q3 Earnings & Sales Beat, Costs Decline (opens in a new tab) Zacks · 06 Nov 2026 13:58
- Novavax Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 06 Nov 2026 10:14
- Novavax Inc (NVAX) (Q3 2026) Earnings Call Highlights: Sanofi Milestone Lifts Revenue Outlook ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 01:15
- Sanofi (ENXTPA:SAN) Could Be 16% Overvalued After Strong Q3 Results And Higher 2026 Guidance (opens in a new tab) Simply Wall St. · 05 Nov 2026 10:22
- Sanofi Stock And Why Earnings Guidance Raised Matters For Shareholders (opens in a new tab) Simply Wall St. · 05 Nov 2026 08:14
- Sanofi (ENXTPA:SAN) Stock Looks Discounted Despite Its 20% Monthly Run (opens in a new tab) Simply Wall St. · 05 Nov 2026 01:16
- Nurix, Sanofi Diverge — And One Breaks Out — On A Shocking Eczema Development (opens in a new tab) Investor's Business Daily · 04 Nov 2026 21:19
- NRIX Stock Clocks Worst Day Ever After Sanofi Discontinues Trial Of Licensed Drug: Wells Fargo Slashes Price Target (opens in a new tab) Stocktwits · 04 Nov 2026 21:14
- Sanofi (ENXTPA:SAN) Drops SAR448272 And Backs New Immunology Candidate (opens in a new tab) Simply Wall St. · 04 Nov 2026 19:14
- Sanofi stops development of Nurix-partnered immune drug (opens in a new tab) BioPharma Dive · 04 Nov 2026 17:18
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 48.46 USD
- Market cap
- 116.2B
- Dividend yield
- 4.99%
- 5-year average yield
- 4.04%
- Payout ratio
- 120%
- Last dividend
- 2.4220 USD · 04 May 2026
- Exchange
- NasdaqGS
- Country
- France
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 04 May 2026 | 2.4220 USD |
| 09 May 2025 | 2.2120 USD |
| 09 May 2024 | 2.0370 USD |
| 30 May 2023 | 1.9030 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow SNY and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.